Open Access

The value of NT-proBNP in cardiovascular risk stratification and optimization of cardioprotective treatment among patients with type 2 diabetes.

Topic: Biomarkers
Sponsored by Roche Diagnostics International

Congress Session

About the speaker

Doctor Muthiah Vaduganathan

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
9 presentations
0 follower

4 more presentations in this session


Speaker: Doctor D. Gualandro (Basel, CH)


The value of high-sensitivity troponin T in patients undergoing noncardiac surgery.

Speaker: Doctor C. Puelacher (Basel, CH)


Using NT-proBNP to screen patients with afib: results from the STROKESTOP II trial.

Speaker: Doctor K. Kemp Gudmundsdottir (Stockholm, SE)


Access the full session

Cardiac biomarkers are here to stay

Speakers: Doctor M. Vaduganathan, Doctor D. Gualandro, Doctor C. Puelacher, Doctor K. Kemp Gudmundsdottir

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ACVC Premium Access

Clinical trial evidence.

18 March 2022

ESC Premium Access

COVID-19 & digital health: is techcelleration here to stay? Let's discuss

22 October 2021

ESC Premium Access

COVID-19 & digital health: techcelleration here to stay?

22 October 2021

This platform is supported by

logo Novo Nordisk